Literature DB >> 18299258

Cross pectoral nerve transfer following free gracilis muscle transplantation for chronic brachial plexus palsy: a case series.

Mohammad Ali Hosseinian1, Arash Mohammadi Tofigh.   

Abstract

In an eight year period, 12 patients were treated by the contra-lateral medial pectoral nerve as motor nerve innervation of the transplanted free gracilis muscle to the paralytic upper limb. The gracilis muscle was used for both elbow and digital flexion. Results were assessed by the MRC grading system and success was defined as muscle strength of M4 and M3 which was observed in seven patients (58%). The motor level of the muscle in two patients was M0 and in two it was M1 to M2. The donor pectoral muscle of these 12 patients showed no deficit in motor and sensory functions. This method can be used for treatment of brachial plexus palsy, regaining useful function of the reconstructed limb.

Entities:  

Mesh:

Year:  2008        PMID: 18299258     DOI: 10.1016/j.ijsu.2008.01.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  3 in total

1.  Medial pectoral nerve to axillary nerve neurotization following traumatic brachial plexus injuries: indications and clinical outcomes.

Authors:  Wilson Z Ray; Rory K J Murphy; Katherine Santosa; Philip J Johnson; Susan E Mackinnon
Journal:  Hand (N Y)       Date:  2011-11-29

2.  Outcome of free gracilis muscle transfer for the restoration of elbow flexion in traumatic brachial plexus palsy.

Authors:  Mehmet Armangil; Seyyid Şerif Ünsal; Tuğrul Yıldırım; Uğur Bezirgan; Anar Keremov; Sinan Adıyaman; Sırrı Sinan Bilgin
Journal:  Jt Dis Relat Surg       Date:  2021-11-19

3.  Functioning free gracilis transfer to reconstruct elbow flexion and quality of life in global brachial plexus injured patients.

Authors:  Yi Yang; Jian-Tao Yang; Guo Fu; Xiang-Ming Li; Ben-Gang Qin; Yi Hou; Jian Qi; Ping Li; Xiao-Lin Liu; Li-Qiang Gu
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.